5Fardel O, Jigorel E, Le Vee M, et al. Physiological, pharmacologi- cal and clinical features of the muhidrug resistance protein 2 [ J]. Bi- omed Pharmacother ,2005 ,59 ( 3 ) : 104-114.
6Reed M J, Meszaros K, Entes LJ, et al. A new rat model of type 2 di- abetes : the fat-fed, streptozotocin-treated rat [ J ]. Metabolism,2000, 49( 11 ) :1390-1394.
7Wei M, Ong L, Smith MT, et al. The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes [ J ]. Heart Lung Circ ,2003,12 ( 1 ) :44-50.
8Zhou G, Myers R, Li Y,et al. Role of AMP-activated protein kinase in mechanism of metformin action [ J ]. J Clin Invest,2001,108 ( 8 ) : 1167-1174.
9Lee JM, Trauner M, Soroka C J, et al. Expression of the bile salt ex- port pump is maintained after chronic choiestasis in the rat [ J]. Gas- troenterology,2000,118 ( 1 ) : 163-172.
10Courtois A, Payen L, Guillouzo A, et al. Up-regulation of multidi'ug protein 2 (MRP2) expression in rat hepatocytes by dexamethasone [J]. FEBS Lett,1999,459(3) :381-385.
